Market closed
HCW Biologics/$HCWB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About HCW Biologics
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
Ticker
$HCWB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
36
Website
HCW Biologics Metrics
BasicAdvanced
$9.3M
-
-$30.96
0.82
-
Price and volume
Market cap
$9.3M
Beta
0.82
52-week high
$10.13
52-week low
$8.05
Financial strength
Current ratio
0.192
Quick ratio
0.177
Long term debt to equity
-108.976
Total debt to equity
-202.248
Interest coverage (TTM)
-46.71%
Management effectiveness
Return on assets (TTM)
-62.72%
Return on equity (TTM)
-897.37%
Valuation
Price to revenue (TTM)
3.132
Price to book
-1.36
Price to tangible book (TTM)
-1.36
Price to free cash flow (TTM)
-0.555
Growth
Revenue change (TTM)
-9.68%
Earnings per share change (TTM)
11.26%
3-year earnings per share growth (CAGR)
4.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for HCW Biologics stock?
HCW Biologics (HCWB) has a market cap of $9.3M as of April 16, 2025.
What is the P/E ratio for HCW Biologics stock?
The price to earnings (P/E) ratio for HCW Biologics (HCWB) stock is 0 as of April 16, 2025.
Does HCW Biologics stock pay dividends?
No, HCW Biologics (HCWB) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next HCW Biologics dividend payment date?
HCW Biologics (HCWB) stock does not pay dividends to its shareholders.
What is the beta indicator for HCW Biologics?
HCW Biologics (HCWB) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.